Clinical Trial Update: A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for trastuzumab combined with TS-ONE and cisplatin as first-line therapy for HER2-positive advanced gastric cancer; current trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• TS-ONE
• Trastuzumab (trastuzumab)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN